GeneReach Biotechnology Corp. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was TWD 365.795 million compared to TWD 187.418 million a year ago. Operating income was TWD 111.941 million compared to TWD 11.376 million a year ago. Net income was TWD 77.180 million compared to TWD 28.571 million a year ago. Basic earnings per share was TWD 2 compared to TWD 0.83 a year ago. Diluted earnings per share was TWD 1.94 compared to TWD 0.78 a year ago.